61 related articles for article (PubMed ID: 9375954)
1. Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2.
Minami T; Okuda-Ashitaka E; Nishizawa M; Mori H; Ito S
Br J Pharmacol; 1997 Oct; 122(4):605-10. PubMed ID: 9375954
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.
Minami T; Okuda-Ashitaka E; Mori H; Ito S; Hayaishi O
J Pharmacol Exp Ther; 1996 Sep; 278(3):1146-52. PubMed ID: 8819497
[TBL] [Abstract][Full Text] [Related]
3. Characterization of nociceptin hyperalgesia and allodynia in conscious mice.
Hara N; Minami T; Okuda-Ashitaka E; Sugimoto T; Sakai M; Onaka M; Mori H; Imanishi T; Shingu K; Ito S
Br J Pharmacol; 1997 Jun; 121(3):401-8. PubMed ID: 9179380
[TBL] [Abstract][Full Text] [Related]
4. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O
Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
[TBL] [Abstract][Full Text] [Related]
5. Characterization of nociceptin/orphanin FQ-induced pain responses in conscious mice: neonatal capsaicin treatment and N-methyl-D-aspartate receptor GluRepsilon subunit knockout mice.
Minami T; Okuda-Ashitaka E; Mori H; Sakimura K; Watanabe M; Mishina M; Ito S
Neuroscience; 2000; 97(1):133-42. PubMed ID: 10771345
[TBL] [Abstract][Full Text] [Related]
6. Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice.
Minami T; Uda R; Horiguchi S; Ito S; Hyodo M; Hayaishi O
Pain; 1994 May; 57(2):217-223. PubMed ID: 7916452
[TBL] [Abstract][Full Text] [Related]
7. Nocistatin, a peptide that blocks nociceptin action in pain transmission.
Okuda-Ashitaka E; Minami T; Tachibana S; Yoshihara Y; Nishiuchi Y; Kimura T; Ito S
Nature; 1998 Mar; 392(6673):286-9. PubMed ID: 9521323
[TBL] [Abstract][Full Text] [Related]
8. Anti-nociceptive responses produced by human putative counterpart of nocistatin.
Minami T; Okuda-Ashitaka E; Nishiuchi Y; Kimura T; Tachibana S; Mori H; Ito S
Br J Pharmacol; 1998 Jul; 124(6):1016-8. PubMed ID: 9720768
[TBL] [Abstract][Full Text] [Related]
9. Blockade by ONO-NT-012, a unique prostanoid analogue, of prostaglandin E2-induced allodynia in conscious mice.
Minami T; Nishihara I; Sakamoto K; Ito S; Hyodo M; Hayaishi O
Br J Pharmacol; 1995 May; 115(1):73-6. PubMed ID: 7647986
[TBL] [Abstract][Full Text] [Related]
10. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice.
Eguchi N; Minami T; Shirafuji N; Kanaoka Y; Tanaka T; Nagata A; Yoshida N; Urade Y; Ito S; Hayaishi O
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):726-30. PubMed ID: 9892701
[TBL] [Abstract][Full Text] [Related]
11. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.
Minami T; Nakano H; Kobayashi T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Ito S
Br J Pharmacol; 2001 Jun; 133(3):438-44. PubMed ID: 11375261
[TBL] [Abstract][Full Text] [Related]
12. Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice.
Minami T; Sugatani J; Sakimura K; Abe M; Mishina M; Ito S
Br J Pharmacol; 1997 Apr; 120(8):1522-6. PubMed ID: 9113374
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive effects of AS1069562, the (+)-isomer of indeloxazine, on spinal hypersensitivity induced by intrathecal injection of prostaglandin in mice: comparison with duloxetine and amitriptyline.
Murai N; Tsukamoto M; Tamura S; Aoki T; Matsuoka N
Eur J Pharmacol; 2014 Jun; 733():54-61. PubMed ID: 24704374
[TBL] [Abstract][Full Text] [Related]
14. Further studies on ocular responses to DP receptor stimulation.
Woodward DF; Spada CS; Hawley SB; Williams LS; Protzman CE; Nieves AL
Eur J Pharmacol; 1993 Jan; 230(3):327-33. PubMed ID: 8440310
[TBL] [Abstract][Full Text] [Related]
15. Involvement of prostaglandin F 2 alpha receptor in ATP-induced mechanical allodynia.
Kunori S; Matsumura S; Mabuchi T; Tatsumi S; Sugimoto Y; Minami T; Ito S
Neuroscience; 2009 Sep; 163(1):362-71. PubMed ID: 19490931
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?
Rangachari PK; Betti PA; Prior ET; Roberts LJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):611-7. PubMed ID: 7473146
[TBL] [Abstract][Full Text] [Related]
17. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.
Hamid-Bloomfield S; Payne AN; Petrovic AA; Whittle BJ
Br J Pharmacol; 1990 Aug; 100(4):761-6. PubMed ID: 2119842
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of nitric oxide release from rat spinal cord by prostaglandin E2.
Sakai M; Minami T; Hara N; Nishihara I; Kitade H; Kamiyama Y; Okuda K; Takahashi H; Mori H; Ito S
Br J Pharmacol; 1998 Mar; 123(5):890-4. PubMed ID: 9535017
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
